Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| RCAX | Tidal Trust II - Defiance Daily Target 2x Long Rcat ETF | $18.28 | $5.11 | 38.79% | 631.1K | - | $11.66$22.31 |
| MVO | Mv Oil Trust | $2.85 | $0.78 | 37.68% | 41.4K | $24M | $0.97$6.60 |
| RLYB | Rallybio | $10.22 | $2.68 | 35.54% | 3.3M | $40M | $1.76$10.70 |
| AURE | Aurelion | $2.12 | $0.50 | 30.86% | 28K | $56M | $1.50$14.60 |
| EMAT | Evolution Metals & Technologies | $10.33 | $2.36 | 29.61% | 621K | $23M | $5.50$24.37 |
| CRCG | Themes ETF Trust - Leverage Shares 2x Long Crcl Daily ETF | $3.07 | $0.67 | 27.92% | 38.4M | - | $0.95$20.92 |
| ASTH | Astrana Health | $26.00 | $5.67 | 27.89% | 105K | $1.0B | $18.08$34.80 |
| CGEN | Compugen | $2.28 | $0.47 | 25.97% | 1.7M | $169M | $1.13$2.38 |
| MGN | Megan | $2.50 | $0.50 | 25.00% | 571.2K | $33M | $1.00$8.63 |
| JFB | Jfb Construction | $18.94 | $3.77 | 24.85% | 295.5K | $96M | $3.39$35.10 |
| DBGI | Digital Brands Group | $3.56 | $0.69 | 24.04% | 916.4K | $24M | $1.77$18.00 |
| ALMU | Aeluma | $19.10 | $3.63 | 23.46% | 1.9M | $279M | $5.79$25.88 |
| FIGR | Figure Technology Solutions | $31.01 | $5.73 | 22.67% | 6.6M | $5.5B | $25.00$78.00 |
| AAOI | Applied Optoelectronics | $102.34 | $18.11 | 21.50% | 23.9M | $5.8B | $9.71$110.00 |
| USGO | U.s. GoldMining | $14.56 | $2.52 | 20.88% | 18.3K | $160M | $7.42$17.98 |
| AXTI | AXT | $45.73 | $7.83 | 20.66% | 11.1M | $2.1B | $1.13$46.83 |
| UUUG | Themes ETF Trust - Leverage Shares 2x Long Uuuu Daily ETF | $18.38 | $3.05 | 19.90% | 329.3K | - | $12.56$30.00 |
| RCUS | Arcus Biosciences | $24.28 | $3.91 | 19.17% | 74.9K | $2.5B | $6.50$26.40 |
| OCUL | Ocular Therapeutix | $10.64 | $1.70 | 19.02% | 455.5K | $1.9B | $5.79$16.44 |
| PURR | Hyperliquid Strategies | $4.82 | $0.74 | 18.20% | 6.5M | $506M | $3.01$5.78 |
| LASR | nLIGHT | $66.37 | $10.18 | 18.12% | 171.9K | $3.1B | $6.20$67.85 |
| BRAI | Braiin | $17.20 | $2.59 | 17.73% | 35.8K | $1.0B | $12.56$98.99 |
| ANNA | AleAnna | $3.33 | $0.48 | 16.84% | 5.4K | $116M | $2.31$18.30 |
| BODI | Beachbody | $8.09 | $1.13 | 16.16% | 48.2K | $49M | $3.38$12.66 |
| NUCL | Eagle Nuclear Energy | $5.57 | $0.76 | 15.68% | 477.1K | $48M | $4.55$9.65 |
Related Articles
Featured Article
1 Small-Cap Stock I'd Buy Before GLBE in 2026
Marc Guberti|Jan 8, 2026
Global-E Online is a small company trying to carve out a niche in the competitive e-commerce space, while AXT is a small semiconductor player that already has a lead in an emerging opportunity.
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024
George Budwell, PhD|Jan 3, 2024
These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.
Can Beachbody Become the Next Peloton?
Michael Byrne|Oct 4, 2021
Beachbody is quietly building a comprehensive digital fitness ecosystem.
This Exciting Biopharma Could Earn You 55% in 12 Months
Jeffrey Little|Aug 22, 2021
When patients see more clearly, so too should investors.
4 Reasons I Just Bought Ocular Therapeutix Stock
Cory Renauer|Aug 21, 2021
This company's drug delivery technology just isn't getting the appreciation it deserves right now.
2 Growth Stocks That Dropped More Than 10% in a Week
Jose Najarro|Jul 6, 2021
Both companies could be providing long-term investors with some great value.
Why Arcus Biosciences' Big Reveal Wasn't Very Exciting
Cory Renauer|Jun 25, 2021
No news from Arcus Biosciences is bad news for the company and other industry heavyweights.
Can Ocular Therapeutix Reach Its Full Potential?
Brian Orelli, PhD and Keith Speights|Apr 1, 2021
The biotech has a ways to go.
![Can_Ocular_Therapeutix_Reach_Its_Full_Potential[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F619459%2Fcan_ocular_therapeutix_reach_its_full_potential1.jpg&w=384&op=resize)
3 Top Healthcare Stocks to Buy Now
Cory Renauer|Feb 17, 2021
Find out how shares of these disruptive businesses could make you rich.
3 Reasons to Buy Ocular Therapeutix Stock Right Now
Cory Renauer|Feb 16, 2021
There are a few reasons this could be the best biotech stock you can buy at the moment.
